ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,759Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 96

$2.01M Total Retail Price of All Prescriptions

Rank: 3 out of 96

818 Patients Receiving at Least One Drug in Part D
42%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 818 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 818 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 3,323 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$171 was the average price of a prescription from this provider, compared to $214 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
HYDROCODONE-ACETAMINOPHEN 1,185 251 S3 1 5
GABAPENTIN 696 220 2 1
TOPIRAMATE 472 122 3 6
LEVETIRACETAM 363 117 4 2
TRAMADOL HCL 322 78 5 24
CARISOPRODOL 313 0 R 6 34
LYRICA 281 87 7 9
BACLOFEN 271 72 8 11
PRAMIPEXOLE DIHYDROCHLORIDE 256 125 9 23
ZOLPIDEM TARTRATE 235 37 10 19
DIVALPROEX SODIUM ER 234 61 11 14
CYMBALTA 227 115 12 13
DONEPEZIL HCL 221 132 13 4
MELOXICAM 211 96 14 41
TIZANIDINE HCL 201 20 15 10
NORTRIPTYLINE HCL 200 44 16 27
OXYCODONE HCL 199 39 S2 17 15
CITALOPRAM HBR 197 65 18 30
OXYCONTIN 193 84 S2 19 42
OXYCODONE HCL-ACETAMINOPHEN 169 31 S2 20 37
MORPHINE SULFATE ER 164 30 S2 21 25
CYCLOBENZAPRINE HCL 161 14 R 22 31
CARBIDOPA-LEVODOPA 160 141 23 3
OXCARBAZEPINE 155 39 24 26
CARBAMAZEPINE 143 49 25 17
SUMATRIPTAN SUCCINATE 137 38 26 28
ENDOCET 131 33 S2 27 61
SERTRALINE HCL 115 32 28 35
NAMENDA 115 81 28 7
PROMETHAZINE HCL 111 0 R 30 44
AMITRIPTYLINE HCL 106 48 R 31 20
LAMOTRIGINE 105 24 32 8
COPAXONE 97 17 33 32
FENTANYL 86 0 S2 34 33
SAVELLA 74 0 35 75
OXYCODONE-ACETAMINOPHEN 72 18 S2 36 38
DOXEPIN HCL 72 0 36 90
KEPPRA 72 0 36 55
MORPHINE SULFATE 72 28 S2 36 58
ESCITALOPRAM OXALATE 71 0 40 53
AMPHETAMINE SALT COMBO 71 12 S2 40 64
MIRTAZAPINE 70 0 42 56
PAROXETINE HCL 68 30 43 62
TRAZODONE HCL 67 21 44 36
METHADONE HCL 63 0 S2 45 40
VENLAFAXINE HCL 56 0 46 104
VERAPAMIL ER 56 0 46 65
VENLAFAXINE HCL ER 55 11 48 45
AMANTADINE 53 0 49 46
PRIMIDONE 51 38 50 12
GILENYA 50 0 51 72
PREDNISONE 50 25 51 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 13, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.